Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1956;14:77-82

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FARQUHAR, J. W.
Right arrow Articles by DEMPSEY, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FARQUHAR, J. W.
Right arrow Articles by DEMPSEY, M. E.
Right arrowPubmed/NCBI databases
*Substance via MeSH

(Circulation. 1956;14:77.)
© 1956 American Heart Association, Inc.


The Effect of Beta Sitosterol on the Serum Lipids of Young Men with Arteriosclerotic Heart Disease

JOHN W. FARQUHAR M.D.1; RALPH E. SMITH M.D.1; MARY E. DEMPSEY M.S.1

1 From the Cardiovascular Disease Laboratory, Veterans Administration Hospital and University of Minnesota, Minneapolis, Minn.

Previous studies in human beings on unrestricted diets have indicated that the plant sterols (beta or gamma sitosterol) cause decreases in serum cholesterol. In this study, 15 young men with previous myocardial infarction were given 12 to 18 Gm./day of beta sitosterol with resultant sustained reductions of serum cholesterol and beta lipoprotein lipid. Lipoprotein lipid fractionation was performed by paper electrophoresis. These changes occurred irrespective of initial serum cholesterol or content of diet. Control observations of the effects of diet, weight maintenance, and the inclusion of placebos brought about increased confidence that the changes were due to the administered sitosterol.




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
P. J. H. Jones, C. A. Vanstone, M. Raeini-Sarjaz, and M.-P. St-Onge
Phytosterols in low- and nonfat beverages as part of a controlled diet fail to lower plasma lipid levels
J. Lipid Res., September 1, 2003; 44(9): 1713 - 1719.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. H. Lichtenstein and R. J. Deckelbaum
Stanol/Sterol Ester-Containing Foods and Blood Cholesterol Levels : A Statement for Healthcare Professionals From the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association
Circulation, February 27, 2001; 103(8): 1177 - 1179.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. J. Jones, M. Raeini-Sarjaz, F. Y. Ntanios, C. A. Vanstone, J. Y. Feng, and W. E. Parsons
Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters
J. Lipid Res., May 1, 2000; 41(5): 697 - 705.
[Abstract] [Full Text]


Home page
J. Am. Coll. Nutr.Home page
C. L. Williams, M. C. Bollella, B. A. Strobino, L. Boccia, and L. Campanaro
Plant Stanol Ester and Bran Fiber in Childhood: Effects on Lipids, Stool Weight and Stool Frequency in Preschool Children
J. Am. Coll. Nutr., December 1, 1999; 18(6): 572 - 581.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. J. Jones, F. Y Ntanios, M. Raeini-Sarjaz, and C. A Vanstone
Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men
Am. J. Clinical Nutrition, June 1, 1999; 69(6): 1144 - 1150.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
H. Gylling, P. Puska, E. Vartiainen, and T. A. Miettinen
Serum sterols during stanol ester feeding in a mildly hypercholesterolemic population
J. Lipid Res., April 1, 1999; 40(4): 593 - 600.
[Abstract] [Full Text]


Home page
NEJMHome page
T. A. Miettinen, P. Puska, H. Gylling, H. Vanhanen, and E. Vartiainen
Reduction of Serum Cholesterol with Sitostanol-Ester Margarine in a Mildly Hypercholesterolemic Population
N. Engl. J. Med., November 16, 1995; 333(20): 1308 - 1312.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
R. I. Levy and C. J. Glueck
Hypertriglyceridemia, Diabetes Mellitus, and Coronary Vessel Disease
Arch Intern Med, March 1, 1969; 123(3): 220 - 228.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
G. C. CHIU
Mode of Action of Cholesterol-Lowering Agents: A Critique of Facts and Theories
Arch Intern Med, November 1, 1961; 108(5): 717 - 732.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
M. P. SAMBHI and H. A. ZIMMERMAN
Progress in the Long-Term Management of Coronary Artery Disease
Arch Intern Med, May 1, 1958; 101(5): 974 - 996.
[Abstract] [PDF]


Home page
Arch SurgHome page
C. G. JOHNSTON and F. NAKAYAMA
Solubility of Cholesterol and Gallstones in Metabolic Material
Arch Surg, September 1, 1957; 75(3): 436 - 442.
[Abstract] [PDF]